Co-Authors
This is a "connection" page, showing publications co-authored by Matthias Tenbusch and Klaus Korn.
Connection Strength
0.581
-
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):751-759.
Score: 0.227
-
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 2021 10; 51(10):2478-2484.
Score: 0.060
-
Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis. 2021 Sep; 40(9):1999-2004.
Score: 0.060
-
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020. Viruses. 2021 06 10; 13(6).
Score: 0.059
-
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis. 2021 Sep; 40(9):1983-1997.
Score: 0.059
-
Pearls & Oy-sters: SARS-CoV-2 Infection of the CNS in a Patient With Meningeosis Carcinomatosa. Neurology. 2021 03 09; 96(10):496-499.
Score: 0.057
-
Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients. Transfusion. 2021 02; 61(2):368-374.
Score: 0.057